Boston Scientific FARAFLEX pivotal trial begins U.S. testing of single map-and-ablate PFA catheter
Texas Cardiac Arrhythmia Institute has performed the first U.S. procedure in Boston Scientific’s 571-patient FARAFLEX pivotal program evaluating integrated mapping and pulsed field ablation for paroxysmal and persistent AF.